Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemother...
Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemotherapy alone in HER2(–) locally advanced gastric cancer: A propensity score-matched cohort study
About this item
Full title
Author / Creator
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Abstract
Background:
This study aims to compare the efficacy between neoadjuvant immune checkpoint inhibitors (ICIs) plus chemotherapy vs. chemotherapy, and neoadjuvant triplet vs. doublet chemotherapeutic regimens in locally advanced gastric/esophagogastric junction cancer (LAGC).
Methods:
We included LAGC patients from 47 hospitals in...
Alternative Titles
Full title
Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemotherapy alone in HER2(–) locally advanced gastric cancer: A propensity score-matched cohort study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4d516e3544b04538a4557bb2301b26d9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d516e3544b04538a4557bb2301b26d9
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000003028
